SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-24-000321
Filing Date
2024-03-28
Accepted
2024-03-28 16:28:26
Documents
2
Group Members
ORBIMED CAPITAL GP VII LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss3202554_sc13d.htm SC 13D 85348
2 JOINT FILING AGREEMENT ss3202554_ex9901.htm EX-99.1 5233
  Complete submission text file 0000947871-24-000321.txt   92233
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 781-999-0232
Q32 Bio Inc. (Subject) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90433 | Film No.: 24799530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)